US Patent Issued to Odyssey Therapeutics on May 12 for "Inhibitors of RIPK2 and medical uses thereof" (Michigan, California, Massachusetts Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,018, issued on May 12, was assigned to Odyssey Therapeutics Inc. (Boston).

"Inhibitors of RIPK2 and medical uses thereof" was invented by Chad VanHuis (Hartland, Mich.), Shifeng Pan (San Diego), Dominik K. Koelmel (Ann Arbor, Mich.), Robert Aversa (Watertown, Mass.), Clarke Taylor (Ann Arbor, Mich.) and Marta Wlodarska (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to RIPK2 inhibitors represented by structural formula (I):The disclosure further relates to pharmaceutical composition comprising the RIPK2 inhibitors and methods of treatment of conditions such as inflammatory diseases, autoimmune diseases,...